24 research outputs found
Global index of muscle activity (Ker-EGI and global EMG-PS) and index of muscle activity for each muscle for the whole gait cycle, stance phase and swing phase (EMG-PS).
<p>Global index of muscle activity (Ker-EGI and global EMG-PS) and index of muscle activity for each muscle for the whole gait cycle, stance phase and swing phase (EMG-PS).</p
Correlations between muscle activation, kinematics and functional status in children with DMD.
<p>Correlations between muscle activation, kinematics and functional status in children with DMD.</p
Illustration of co-activation index (CI) calculation.
<p>The percentage of the gait cycle is presented on the X-axis (0: heel strike, 100: the following ipsilateral heel strike) and the normalized amplitude of EMG activity on the Y-axis (0–1). Lines represent the mean linear envelope of muscle 1 activation. Dashed lines represent the mean linear envelope of muscle 2 activation. Black color represent muscle activation in the control group. Blue color represent muscle activation in one child with DMD. The calculation index involved overlapping the linear envelopes of muscle 1 and muscle 2, calculating the area of overlap and dividing by the number of data points. Areas of coactivation are represented in grey (control group) and in blue (DMD patient).</p
Reliability parameters for SMA patients.
<p>** p-value < 0.01.</p><p>Reliability parameters for SMA patients.</p
Clinical data of all SMA patients sorted by age.
<p>FVC—Forced vital capacity (% of predicted values), NNV—nasal nocturnal ventilation, NA- not available.</p><p>Clinical data of all SMA patients sorted by age.</p
Correlation between MyoSets at baseline on dominant (D) and non-dominant (ND) sides, clinical and motor function parameters.
<p>* p-value < 0.05,</p><p>** p-value < 0.01.</p><p>Correlation between MyoSets at baseline on dominant (D) and non-dominant (ND) sides, clinical and motor function parameters.</p
MoviPlate correlations with grip and pinch strength.
<p>Correlations at baseline between the MoviPlate scores and grip and pinch strength for all SMA patients for the non-dominant hands (dark dots) and the dominant hands (clear dots).</p
Comparison of strength and motor function between the two groups on dominant (D) and non-dominant (ND) sides.
<p>* p-value < 0.05 for group effect,</p><p>** p-value < 0.01 for group effect.</p><p>Comparison of strength and motor function between the two groups on dominant (D) and non-dominant (ND) sides.</p